_id
690db387ccc777a4e85d0cee
Ticker
AVEFF
Name
Avecho Biotechnology Limited
Exchange
PINK
Address
Hallmarc Business Park, Clayton, VIC, Australia, 3168
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://avecho.com.au
Description
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Last Close
0.003
Volume
300000
Current Price
0.0045
Change
0
Last Updated
2026-01-20T15:59:55.337Z
Image
-
Ipo Date
-
Market Cap
16530585
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
560069
Cost Of Revenue
165168
Gross Profit
394901
Operating Expenses
3794827
Operating Income
-3399926
Interest Expense
-
Pretax Income
-2675960
Net Income
-2675960
Eps
-0.000843866694942426
Dividends Per Share
-
Shares Outstanding
3673463679
Income Tax Expense
-
EBITDA
-2538923
Operating Margin
-607.0548450280234
Total Other Income Expense Net
723966
Cash
5934020
Short Term Investments
-
Receivables
895311
Inventories
137508
Total Current Assets
7074125
Property Plant Equipment
102356
Total Assets
7192211
Payables
660980
Short Term Debt
57123
Long Term Debt
-
Total Liabilities
6367051
Equity
825160
Bs_currency_symbol
-
Depreciation
68428
Change In Working Capital
-
Cash From Operations
4532100
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-972614
Net Change In Cash
5934020
Cf_currency_symbol
-
PE
-
PB
17.293389256023072
ROE
-324.2958941296234
ROA
-37.206361159315264
FCF
4532100
Fcf Percent
8.09203865952231
Piotroski FScore
2
Health Score
28
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
4.5
Quality Investing Score
3
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
560069
Quarters > 0 > income Statement > cost Of Revenue
165168
Quarters > 0 > income Statement > gross Profit
394901
Quarters > 0 > income Statement > operating Expenses
3794827
Quarters > 0 > income Statement > operating Income
-3399926
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2675960
Quarters > 0 > income Statement > net Income
-2675960
Quarters > 0 > income Statement > eps
-0.000843866694942426
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3171069573
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2538923
Quarters > 0 > income Statement > operating Margin
-607.0548450280234
Quarters > 0 > income Statement > total Other Income Expense Net
723966
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
5934020
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
895311
Quarters > 0 > balance Sheet > inventories
137508
Quarters > 0 > balance Sheet > total Current Assets
7074125
Quarters > 0 > balance Sheet > property Plant Equipment
102356
Quarters > 0 > balance Sheet > total Assets
7192211
Quarters > 0 > balance Sheet > payables
660980
Quarters > 0 > balance Sheet > short Term Debt
57123
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6367051
Quarters > 0 > balance Sheet > equity
825160
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-2675960
Quarters > 0 > cash Flow > depreciation
68428
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
4532100
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-972614
Quarters > 0 > cash Flow > net Change In Cash
5934020
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.000843866694942426
Quarters > 0 > ratios > PB
17.293389256023072
Quarters > 0 > ratios > ROE
-324.2958941296234
Quarters > 0 > ratios > ROA
-37.206361159315264
Quarters > 0 > ratios > FCF
4532100
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
8.09203865952231
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
820484
Quarters > 1 > income Statement > cost Of Revenue
355754
Quarters > 1 > income Statement > gross Profit
464730
Quarters > 1 > income Statement > operating Expenses
2528000
Quarters > 1 > income Statement > operating Income
-2064000
Quarters > 1 > income Statement > interest Expense
51544
Quarters > 1 > income Statement > pretax Income
-946000
Quarters > 1 > income Statement > net Income
-946000
Quarters > 1 > income Statement > eps
-0.0002984889077924852
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3169297000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-826000
Quarters > 1 > income Statement > operating Margin
-251.55883600411465
Quarters > 1 > income Statement > total Other Income Expense Net
1117058
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
2374534
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2246461
Quarters > 1 > balance Sheet > inventories
137459
Quarters > 1 > balance Sheet > total Current Assets
4810277
Quarters > 1 > balance Sheet > property Plant Equipment
170784
Quarters > 1 > balance Sheet > total Assets
4996791
Quarters > 1 > balance Sheet > payables
60634
Quarters > 1 > balance Sheet > short Term Debt
1062196
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1727053
Quarters > 1 > balance Sheet > equity
3269738
Quarters > 1 > balance Sheet > currency_symbol
AUD
Quarters > 1 > cash Flow > net Income
2175252
Quarters > 1 > cash Flow > depreciation
-74714
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
628246
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-15730
Quarters > 1 > cash Flow > cash From Financing
892328
Quarters > 1 > cash Flow > net Change In Cash
-3129862
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0002984889077924852
Quarters > 1 > ratios > PB
4.361767364846969
Quarters > 1 > ratios > ROE
-28.931981706179517
Quarters > 1 > ratios > ROA
-18.932150654289924
Quarters > 1 > ratios > FCF
628246
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.7657017077724855
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
410242
Quarters > 2 > income Statement > cost Of Revenue
177877
Quarters > 2 > income Statement > gross Profit
232365
Quarters > 2 > income Statement > operating Expenses
1264000
Quarters > 2 > income Statement > operating Income
-1032000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-473000
Quarters > 2 > income Statement > net Income
-473000
Quarters > 2 > income Statement > eps
-0.0001492444538962426
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3169297000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-413000
Quarters > 2 > income Statement > operating Margin
-251.55883600411465
Quarters > 2 > income Statement > total Other Income Expense Net
558529
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
35086
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0001492444538962426
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
312188
Quarters > 3 > income Statement > cost Of Revenue
104992
Quarters > 3 > income Statement > gross Profit
207196
Quarters > 3 > income Statement > operating Expenses
3102000
Quarters > 3 > income Statement > operating Income
-2894000
Quarters > 3 > income Statement > interest Expense
5590
Quarters > 3 > income Statement > pretax Income
-2176000
Quarters > 3 > income Statement > net Income
-2176000
Quarters > 3 > income Statement > eps
-0.0006865875934000506
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3169297000
Quarters > 3 > income Statement > income Tax Expense
-523730
Quarters > 3 > income Statement > EBITDA
-2094000
Quarters > 3 > income Statement > operating Margin
-927.0055223134777
Quarters > 3 > income Statement > total Other Income Expense Net
719592
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
4838410
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
549325
Quarters > 3 > balance Sheet > inventories
96118
Quarters > 3 > balance Sheet > total Current Assets
5623620
Quarters > 3 > balance Sheet > property Plant Equipment
240955
Quarters > 3 > balance Sheet > total Assets
5864575
Quarters > 3 > balance Sheet > payables
975192
Quarters > 3 > balance Sheet > short Term Debt
80288
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1648040
Quarters > 3 > balance Sheet > equity
4216535
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-2175252
Quarters > 3 > cash Flow > depreciation
74714
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-628246
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-37742
Quarters > 3 > cash Flow > net Change In Cash
-665986
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0006865875934000506
Quarters > 3 > ratios > PB
3.382359330587793
Quarters > 3 > ratios > ROE
-51.60635450672175
Quarters > 3 > ratios > ROA
-37.10413798101312
Quarters > 3 > ratios > FCF
-628246
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.01239637654234
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1294000
Annuals > 0 > income Statement > cost Of Revenue
460746
Annuals > 0 > income Statement > gross Profit
833177
Annuals > 0 > income Statement > operating Expenses
5631000
Annuals > 0 > income Statement > operating Income
-4797000
Annuals > 0 > income Statement > interest Expense
57133
Annuals > 0 > income Statement > pretax Income
-3122000
Annuals > 0 > income Statement > net Income
-3122000
Annuals > 0 > income Statement > eps
-0.0009850765011925357
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3169297000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-2920000
Annuals > 0 > income Statement > operating Margin
-370.71097372488407
Annuals > 0 > income Statement > total Other Income Expense Net
1675000
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
2374534
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2246461
Annuals > 0 > balance Sheet > inventories
137459
Annuals > 0 > balance Sheet > total Current Assets
4810277
Annuals > 0 > balance Sheet > property Plant Equipment
170784
Annuals > 0 > balance Sheet > total Assets
4996791
Annuals > 0 > balance Sheet > payables
60634
Annuals > 0 > balance Sheet > short Term Debt
1062196
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1727053
Annuals > 0 > balance Sheet > equity
3269738
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-3122048
Annuals > 0 > cash Flow > depreciation
144885
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-15730
Annuals > 0 > cash Flow > cash From Financing
854586
Annuals > 0 > cash Flow > net Change In Cash
-3129862
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.0009850765011925357
Annuals > 0 > ratios > PB
4.361767364846969
Annuals > 0 > ratios > ROE
-95.48165632842753
Annuals > 0 > ratios > ROA
-62.480099728005435
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
473551
Annuals > 1 > income Statement > cost Of Revenue
517346
Annuals > 1 > income Statement > gross Profit
-43795
Annuals > 1 > income Statement > operating Expenses
4724000
Annuals > 1 > income Statement > operating Income
-4589000
Annuals > 1 > income Statement > interest Expense
15356
Annuals > 1 > income Statement > pretax Income
-3437000
Annuals > 1 > income Statement > net Income
-3437000
Annuals > 1 > income Statement > eps
-0.001515375973729368
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2268084000
Annuals > 1 > income Statement > income Tax Expense
-1075567
Annuals > 1 > income Statement > EBITDA
-3243000
Annuals > 1 > income Statement > operating Margin
-969.0614104922172
Annuals > 1 > income Statement > total Other Income Expense Net
1153000
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
5504396
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1099563
Annuals > 1 > balance Sheet > inventories
97117
Annuals > 1 > balance Sheet > total Current Assets
7003642
Annuals > 1 > balance Sheet > property Plant Equipment
315668
Annuals > 1 > balance Sheet > total Assets
7319310
Annuals > 1 > balance Sheet > payables
94903
Annuals > 1 > balance Sheet > short Term Debt
76926
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
941540
Annuals > 1 > balance Sheet > equity
6377770
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-3436561
Annuals > 1 > cash Flow > depreciation
178695
Annuals > 1 > cash Flow > change In Working Capital
-453968
Annuals > 1 > cash Flow > cash From Operations
-3179955
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
7216141
Annuals > 1 > cash Flow > net Change In Cash
4036186
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.001515375973729368
Annuals > 1 > ratios > PB
1.6003051223233198
Annuals > 1 > ratios > ROE
-53.8903096223288
Annuals > 1 > ratios > ROA
-46.95797827937333
Annuals > 1 > ratios > FCF
-3179955
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-6.715126776207843
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1206000
Annuals > 2 > income Statement > cost Of Revenue
336142
Annuals > 2 > income Statement > gross Profit
870025
Annuals > 2 > income Statement > operating Expenses
3857000
Annuals > 2 > income Statement > operating Income
-3064000
Annuals > 2 > income Statement > interest Expense
6349
Annuals > 2 > income Statement > pretax Income
-2342000
Annuals > 2 > income Statement > net Income
-2342000
Annuals > 2 > income Statement > eps
-0.0012743019224982846
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1837869000
Annuals > 2 > income Statement > income Tax Expense
652918
Annuals > 2 > income Statement > EBITDA
-2106000
Annuals > 2 > income Statement > operating Margin
-254.06301824212272
Annuals > 2 > income Statement > total Other Income Expense Net
644567
Annuals > 2 > income Statement > currency_symbol
AUD
Annuals > 2 > balance Sheet > cash
1468210
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
745994
Annuals > 2 > balance Sheet > inventories
401979
Annuals > 2 > balance Sheet > total Current Assets
2851189
Annuals > 2 > balance Sheet > property Plant Equipment
468113
Annuals > 2 > balance Sheet > total Assets
3345552
Annuals > 2 > balance Sheet > payables
191191
Annuals > 2 > balance Sheet > short Term Debt
70923
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
920656
Annuals > 2 > balance Sheet > equity
2424896
Annuals > 2 > balance Sheet > currency_symbol
AUD
Annuals > 2 > cash Flow > net Income
-2342391
Annuals > 2 > cash Flow > depreciation
230351
Annuals > 2 > cash Flow > change In Working Capital
241617
Annuals > 2 > cash Flow > cash From Operations
-1665207
Annuals > 2 > cash Flow > capital Expenditures
53124
Annuals > 2 > cash Flow > cash From Investing
-53124
Annuals > 2 > cash Flow > cash From Financing
-78223
Annuals > 2 > cash Flow > net Change In Cash
-1796554
Annuals > 2 > cash Flow > currency_symbol
AUD
Annuals > 2 > ratios > PE
-0.0012743019224982846
Annuals > 2 > ratios > PB
3.4106248267966954
Annuals > 2 > ratios > ROE
-96.58146163794241
Annuals > 2 > ratios > ROA
-70.00339555325998
Annuals > 2 > ratios > FCF
-1718331
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.424818407960199
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
793600
Annuals > 3 > income Statement > cost Of Revenue
285663
Annuals > 3 > income Statement > gross Profit
507937
Annuals > 3 > income Statement > operating Expenses
5059000
Annuals > 3 > income Statement > operating Income
-4551000
Annuals > 3 > income Statement > interest Expense
9975
Annuals > 3 > income Statement > pretax Income
-3416000
Annuals > 3 > income Statement > net Income
-3416000
Annuals > 3 > income Statement > eps
-0.0018953885352297577
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1802269000
Annuals > 3 > income Statement > income Tax Expense
1154000
Annuals > 3 > income Statement > EBITDA
-2978000
Annuals > 3 > income Statement > operating Margin
-573.4627016129032
Annuals > 3 > income Statement > total Other Income Expense Net
1135000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
3264764
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1126994
Annuals > 3 > balance Sheet > inventories
196732
Annuals > 3 > balance Sheet > total Current Assets
4807734
Annuals > 3 > balance Sheet > property Plant Equipment
336215
Annuals > 3 > balance Sheet > total Assets
5245949
Annuals > 3 > balance Sheet > payables
75184
Annuals > 3 > balance Sheet > short Term Debt
80211
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
709359
Annuals > 3 > balance Sheet > equity
4536590
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3416116
Annuals > 3 > cash Flow > depreciation
428594
Annuals > 3 > cash Flow > change In Working Capital
-690936
Annuals > 3 > cash Flow > cash From Operations
-3098674
Annuals > 3 > cash Flow > capital Expenditures
202821
Annuals > 3 > cash Flow > cash From Investing
-202290
Annuals > 3 > cash Flow > cash From Financing
4693483
Annuals > 3 > cash Flow > net Change In Cash
1391988
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.0018953885352297577
Annuals > 3 > ratios > PB
1.7877327464020332
Annuals > 3 > ratios > ROE
-75.29884781300493
Annuals > 3 > ratios > ROA
-65.1169121163778
Annuals > 3 > ratios > FCF
-3301495
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.160149949596774
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.000843866694942426
Valuation > metrics > PB
17.293389256023072
Valuation > final Score
20
Valuation > verdict
476.4% Overvalued
Profitability > metrics > ROE
-324.2958941296234
Profitability > metrics > ROA
-37.82743448836429
Profitability > metrics > Net Margin
-4.777911293072818
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
7.716141112026758
Risk > metrics > Interest Coverage
-24.810277516291222
Risk > final Score
-93
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.851128598543664
Liquidity > metrics > Quick Ratio
9.659640747914993
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
36.38232635153031
Prev Valuations > 1
50
Prev Valuations > 2
46.17640669412207
Prev Profitabilities > 0
0
Prev Profitabilities > 1
35
Prev Profitabilities > 2
0
Prev Risks > 0
-112
Prev Risks > 1
-39
Prev Risks > 2
-2011
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T21:26:26.563Z
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Avecho Biotechnology Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.